Target audience: Baystate Health pharmacists

For questions or more information about the program, please contact Frank Szczerba via email at Frank.Szczerba@baystatehealth.org

Objectives

After participating in this educational activity, attendees should be able to:

1| Review the pathophysiology, clinical presentation, and diagnosis of COPD
2| Describe the updates made to the 2024 GOLD guidelines
3| Explain the place in therapy of COPD management
4| Discuss a COPD patient case
Faculty
Lauren Sieracki, PharmD
PGY2 Pharmacy Resident, Ambulatory Care
Pharmacist
Baystate Medical Center 
Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

                                                                             

Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Pharmacists
Baystate Health designates this activity for a maximum of 1.0 contact hours (s) for pharmacists. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. 

Session date: 
11/11/2024 - 2:00pm to 3:00pm EST
Location: 
MA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.